• Latest Posts

Positive antibody persistence for vaccine treating mosquito disease

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Chikungunya Vaccine First to Succeed in Phase III Trial 

The Top European Biotech Investment Rounds in May

Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal

Update: Single-Shot Vaccine for Chikungunya Lasts for a Year in Phase I

Interview 4 Sep 2019

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

More News! 20 Nov 2018

Phase I Gives Hope for First Zika Vaccine

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

[Update] Valneva’s duck stem cells attract two new Vaccine-deals

Valneva penetrates Chinese Market thanks to a license agreement

An Anglo-French Partnership To Cure Hepatitis B